Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-12-03 00:00:00 ET · period of report 2024-12-02 · accession 0001649094-24-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-03 | 2024-12-02 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale | $92.45 | -15.0K | 454.0K | -3% | -$1.39M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | S | D | 1,409 | $93.06 | 452,543 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $92.72 to $93.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-12-02 | S | D | 2,242 | $94.06 | 450,301 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $93.72 to $94.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-12-02 | S | D | 11,349 | $92.06 | 453,952 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $91.68 to $92.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |